Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other ... Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Show more
– Late-Breaker Poster Presentation Highlights Favorable Safety & Tolerability of OLC – – Two Publications Recently Issued Featuring OLC and UNI-494 – LOS ALTOS, Calif., Oct. 28, 2024 (GLOBE...
LOS ALTOS, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease...
LOS ALTOS, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.13 | 28.2608695652 | 0.46 | 0.6067 | 0.45101 | 1061899 | 0.52325571 | CS |
| 4 | 0.0968 | 19.6269261963 | 0.4932 | 0.61 | 0.4139 | 1735373 | 0.51147554 | CS |
| 12 | 0.2403 | 68.716042322 | 0.3497 | 0.61 | 0.2833 | 1588609 | 0.44298031 | CS |
| 26 | -0.3525 | -37.400530504 | 0.9425 | 0.960641 | 0.202 | 1892776 | 0.42088695 | CS |
| 52 | -0.04 | -6.34920634921 | 0.63 | 1.818 | 0.202 | 1111880 | 0.52829222 | CS |
| 156 | -2.23 | -79.0780141844 | 2.82 | 3.0499 | 0.202 | 922626 | 1.22222096 | CS |
| 260 | -7.96 | -93.0994152047 | 8.55 | 8.73 | 0.202 | 899570 | 1.46620364 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
